Dr. Bozoki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
170 Manning Drive, CB 7025
Chapel Hill, NC 27599Phone+1 919-843-1220
Summary
- I am a research-focused neurologist with interests in clinical trials of anti-dementia therapies and multi-modal theragnostic biomarker development.
Education & Training
- University of Michigan Health SystemFellowship, Behavioral and Geriatric Neurology, 1999 - 2001
- University of Michigan Health SystemFellowship, Behavioral Neurology, 1997 - 1999
- University of MichiganResidency, Neurology, 1994 - 1997
- Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1993 - 1994
- State University of New York Downstate Medical Center College of MedicineClass of 1993
Certifications & Licensure
- NC State Medical License 2020 - 2025
- MI State Medical License 1997 - 2022
- IN State Medical License 2020 - 2021
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation.Bruno Dubois, Nicolas Villain, Lon Schneider, Nick Fox, Noll Campbell
JAMA Neurology. 2024-11-01 - 112 citationsPredicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification.Igor O. Korolev, Laura L. Symonds, Andrea Bozoki, Alzheimer’s Disease Neuroimaging Initiative
Plos One. 2016-02-22 - 67 citationsDisruption of limbic white matter pathways in mild cognitive impairment and Alzheimer's disease: a DTI/FDG-PET studyAndrea Bozoki, Igor O. Korolev, Nathan C. Davis, Lori A. Hoisington, Kevin Berger
Human Brain Mapping. 2012-08-01
Press Mentions
- Duke, UNC Awarded Grant to Establish Joint Alzheimer’s Disease Research CenterSeptember 9th, 2021
- Clinical Effects of the Self-Administered Subcutaneous Complement Inhibitor Zilucoplan in Patients with Moderate to Severe Generalized Myasthenia GravisFebruary 17th, 2020
- The Plan to Diagnose Alzheimer’s in People with No Memory ProblemsFebruary 15th, 2024
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- Hungarian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: